ON
← Back to feed
elDiario.es logo🏛️ Politics
Spain🏛️ PoliticsLean Progressive7 days ago

The dream of buying eternal life: an old aspiration between reality and delusion

The article discusses the growing obsession among global elites with extending human lifespan through biotechnology, highlighting a conversation between Chinese President Xi Jinping and Russian President Vladimir Putin in September 2025 where they speculated about potential immortality through organ transplants and scientific advancements. It traces this trend back to around 2010, when Silicon Valley entrepreneurs began showing interest in longevity research, leading to breakthroughs such as extending mouse lifespans through cellular reprogramming and testing substances like rapamycin. The piece also references the 'biohacker' movement and the 2014 TV series 'Silicon Valley,' which depicted anti-aging techniques. In 2019, the company Ambrosia started offering young blood transfusions as a treatment, reflecting the increasing commercialization of life extension technologies.

The gap in life expectancy continues to widen along socioeconomic lines, with disparities growing more pronounced in urban areas such as Seville, where wealthier neighborhoods enjoy up to 8.8 years more of life than poorer ones. Globally, these differences are even starker, with residents in Monaco living beyond 87 years while many in Nigeria have yet to reach their sixties. This disparity reflects deep-rooted inequalities that persist despite global efforts to improve health outcomes. In recent decades, however, there has been a notable decline in this gap, making it one of the few indicators of inequality that has not increased over time. The reduction in child mortality rates and improvements in vaccination programs have played key roles in narrowing the divide. Paradoxically, the extension of human lifespan has become one of the greatest achievements in promoting equality, as it has benefited populations across different economic backgrounds. Life expectancy data encapsulates a range of critical factors, including infant mortality, access to clean water, and the availability of basic healthcare infrastructure. In Spain, for instance, life expectancy has risen dramatically, from around 73 years in the early years of the country’s modern era to nearly 84 today. Looking further back, the increase was even more remarkable, with life expectancy in 1926 hovering near 40 years. These gains were not due to miraculous medical breakthroughs alone, but rather to collective societal decisions aimed at eliminating preventable causes of death. The twentieth century marked a turning point in human longevity, driven by public policies that ensured access to clean water, vaccines, antibiotics, and universal healthcare systems. These measures allowed people to live longer lives, largely because they prevented deaths caused by treatable conditions. Longevity became a shared achievement, not just a privilege of the wealthy. Now, as we enter the twenty-first century, the focus is shifting toward extending life beyond its natural limits. Scientific advancements suggest that it may soon be possible to slow aging itself through methods such as gene therapy, stem cell treatments, and drugs targeting cellular aging processes. However, these developments raise complex ethical and practical questions. While research into anti-aging technologies is advancing rapidly, the question remains whether these innovations will be accessible to all or remain the domain of the affluent. Investment in longevity research is substantial, driven by the potential for immense financial returns. Those with the means to fund such work include technocrats and ultra-wealthy individuals who already hold considerable influence. The implications of such progress could be profound, especially as leaders like Vladimir Putin and Xi Jinping have publicly expressed interest in achieving immortality. Such ambitions highlight the growing tension between scientific possibility and social equity. Ultimately, the challenge lies in ensuring that future advances in longevity benefit everyone, not just a select few. As science moves closer to the goal of indefinite lifespans, society must grapple with how to distribute these benefits fairly. Whether such breakthroughs will lead to greater equality or deepen existing divides depends on the choices made in the coming years.

Go to the primary sources (1)

The official sources this coverage is built on. Read them directly to bypass framing.

2 reports

elDiario.es logoelDiario.esIndependentCenterFactual 85Objective 707 days ago
The dream of buying eternal life: an old aspiration between reality and delusion

The article discusses the growing obsession among global elites with extending human lifespan through biotechnology, highlighting a conversation between Chinese President Xi Jinping and Russian President Vladimir Putin in September 2025 where they speculated about potential immortality through organ transplants and scientific advancements. It traces this trend back to around 2010, when Silicon Valley entrepreneurs began showing interest in longevity research, leading to breakthroughs such as extending mouse lifespans through cellular reprogramming and testing substances like rapamycin. The piece also references the 'biohacker' movement and the 2014 TV series 'Silicon Valley,' which depicted anti-aging techniques. In 2019, the company Ambrosia started offering young blood transfusions as a treatment, reflecting the increasing commercialization of life extension technologies.

Bias read (Center): While the article touches on political figures (Xi Jinping and Putin), its focus is more on the broader implications of biotech advancements and their societal impact rather than partisan politics. The framing remains balanced, presenting both scientific progress and ethical concerns without overtly

Why factuality (85): The article references a conversation between Xi Jinping and Vladimir Putin regarding biotechnology and immortality, but this specific dialogue is not mentioned in the primary source document. The article also discusses advancements in longevity science and mentions Bryan Johnson and other figures,

Why objectivity (70): The article presents the topic with a somewhat sensational tone, using phrases like 'dream of buying eternal life' and 'delirium.' It frames the discussion around elite obsession with immortality, which may introduce a biased perspective rather than presenting a neutral analysis of the scientific de

elDiario.es logoelDiario.esIndependentProgressiveFactual 75Objective 858 days ago
How many years of life can you afford?

The article discusses the disparity in life expectancy between different socioeconomic groups and regions, highlighting significant differences within cities like Seville and between countries such as Monaco and Nigeria. It notes that while life expectancy has increased globally over the past century due to public health policies, inequalities persist. The piece emphasizes that this progress was achieved through collective efforts in areas like clean water, vaccinations, and universal healthcare systems. However, it raises concerns about future advancements in longevity technologies, such as genetic therapies and anti-aging treatments, and questions whether these will become accessible to all or remain exclusive to the wealthy.

Bias read (Progressive): The article frames the discussion around the accessibility of life-extending technologies, suggesting that they may become a privilege rather than a right. This implies a critique of current economic structures and power dynamics, aligning more closely with left-wing perspectives that emphasize egal

Why factuality (75): The article provides general information about life expectancy disparities between regions and countries, citing specific examples like Seville and Monaco. It references historical improvements in life expectancy in Spain but does not cite primary sources or data from the Revista 51 document. The co

Why objectivity (85): The article presents facts in a largely neutral manner, acknowledging both the progress made in reducing inequality through public health policies and the ongoing challenges. However, it includes phrases like 'esa brecha se está reduciendo' and 'ojalá las diferencias...' which slightly imply a hopef

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.

Become a Supporter

Related stories